ROTH — PharmaRoth Labs Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual income statement for PharmaRoth Labs, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2006 June 30th | 2007 June 30th | 2008 June 30th | 2009 June 30th | 2010 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K/A | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 0 | 0.011 | 0.035 | 0.013 | 0.27 |
| Operating Profit | 0 | -0.011 | -0.035 | -0.013 | -0.27 |
| Net Income Before Taxes | 0 | -0.011 | -0.035 | -0.013 | -0.27 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 0 | -0.011 | -0.035 | -0.013 | -0.27 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 0 | -0.011 | -0.035 | -0.013 | -0.27 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 0 | -0.011 | -0.035 | -0.013 | -0.27 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0 | -0 | -0 | -0 | -0 |
| Dividends per Share |